CNPT in Transition
August 23, 2017
Clinical Neuropsychopharmacology and Therapeutics (CNPT) is entering a new era. Professor Tsuyoshi Kondo, who was superb as CNPT’s Editor-in-Chief for the past seven years, retired to the role of Editor Emeritus. He edited the first issue of CNPT in 2010 and steered the journal until 2016. CNPT is the journal of the Japanese Society of Clinical Neuropsychopharmacology.
CNPT has always focused on clinical psychopharmacology. Regrettably, the number of submissions and articles published is small: 8 in 2010, 11 in 2011, 10 in 2012, 5 in 2013, 7 in 2014, 3 in 2015, and 7 in 2016. Dr Norio Yasui-Furukori told me his thoughtful idea that CNPT should appear in PUBMED and get an impact factor in order to further enhance the value. I completely agreed with him and at the moment we are planning for PUBMED and impact factor.
As the second Editor-in-Chief, I always make an effort to improve turnaround times (i.e. submission to the first decision, 2 weeks; submission to acceptance; 6 weeks). To make a success in this goal, it is necessary to cooperate with editorial members, reviewers and authors. As new and energetic editorial members, Dr Norio Yasui-Furukori as Vice Editor-in-Chief, Dr Junji Saruwatari, Dr Takefumi Suzuki, Dr Hikaru Hori, and Dr Kazuo Mihara kindly participate in our Editorial Board.
With the help of an active editorial board and our powerful reviewers, and with the support of Convention Linkage and Kyorinsha, I hope to steer CNPT for the fruitful development of clinical neuropsychopharmacology.
Takeshi Terao, MD, PhD
Editor-in-Chief of CNPT
Professor, Department of Neuropsychiatry, Oita University Faculty of Medicine